O. Mendoza

Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts

P. Muganda, O. Mendoza, J. Hernandez, 1994, Journal of virology.

Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2)

D. Alonso, O. Mendoza, Ernesto López, 2004, Cancer Research.

Comparative in vitro and experimental in vivo studies of the anti-epidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants.

A. Triguero, O. Mendoza, V. Huerta, 2013, Plant biotechnology journal.

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

D. Alonso, O. Mendoza, Y. Perera, 2008, Molecular and Cellular Biochemistry.

Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB‐552 in mouse models

I. Fichtner, O. Mendoza, M. Bollati-Fogolín, 2014, Journal of peptide science : an official publication of the European Peptide Society.

Identification of a novel antitumor peptide based on the screening of an Ala‐library derived from the LALF32–51 region

O. Mendoza, G. Guillén, H. Garay, 2010, Journal of peptide science : an official publication of the European Peptide Society.

A NOVEL STRATEGY TO IMPROVE ANTIGEN PRESENTATION FOR ACTIVE IMMUNOTHERAPY IN CANCER. FUSION OF THE HUMAN PAPILLOMAVIRUS TYPE 16 E7 ANTIGEN TO A CELL PENETRATING PEPTIDE

O. Mendoza, V. Falcón, M. Granadillo, 2014 .

Effect of human epidermal growth factor on the tumor cell line A431: in vivo analysis of tumor growth inhibition and gene expression

M. Ochagavía, O. Mendoza, K. Cosme, 2012 .